Teladoc Health Inc
TDOC7.890USD
+0.990+14.35%
Cierre 06/23, 16:00（ET）Cotizaciones retrasadas 15 min
1.38BCap. mercado
PérdidaP/E TTM
Más Datos de Teladoc Health Inc Compañía
Teladoc Health, Inc. provides virtual healthcare services. The Company operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. The Integrated Care segment includes a suite of global virtual medical services including general medical, medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed primarily on a business-to-business (B2B) basis. The BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians, leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs.
Información de la empresa
Símbolo de cotizaciónTDOC
Nombre de la empresaTeladoc Health Inc
Fecha de salida a bolsaJul 01, 2015
Fundada en2008
Director ejecutivoMr. Charles (Chuck) Divita, III
Número de empleados5500
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 01
Dirección155 E 44Th Street
CiudadNEW YORK
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal10017
Teléfono12036352002
Sitio Webhttps://www.teladochealth.com/
Símbolo de cotizaciónTDOC
Fecha de salida a bolsaJul 01, 2015
Fundada en2008
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Charles (Chuck) Divita, III
Mr. Charles (Chuck) Divita, III
Chief Executive Officer, Director
Chief Executive Officer, Director
156.64K
--
Ms. Mala Murthy
Ms. Mala Murthy
Chief Financial Officer
Chief Financial Officer
132.44K
-9.47%
Mr. Adam C. Vandervoort, J.D.
Mr. Adam C. Vandervoort, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
69.77K
-7.68%
Ms. Kelly Bliss
Ms. Kelly Bliss
President, U.S. Group Health
President, U.S. Group Health
50.27K
-8.47%
Ms. Sandra L. Fenwick
Ms. Sandra L. Fenwick
Independent Director
Independent Director
40.43K
--
Mr. David L. Shedlarz
Mr. David L. Shedlarz
Independent Director
Independent Director
32.28K
+117.92%
Dr. Mark Douglas Smith, M.D.
Dr. Mark Douglas Smith, M.D.
Independent Director
Independent Director
8.36K
--
Mr. David B. Snow, Jr.
Mr. David B. Snow, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. J. Eric Evans
Mr. J. Eric Evans
Independent Director
Independent Director
--
--
Mr. Thomas G. Mckinley
Mr. Thomas G. Mckinley
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Charles (Chuck) Divita, III
Mr. Charles (Chuck) Divita, III
Chief Executive Officer, Director
Chief Executive Officer, Director
156.64K
--
Ms. Mala Murthy
Ms. Mala Murthy
Chief Financial Officer
Chief Financial Officer
132.44K
-9.47%
Mr. Adam C. Vandervoort, J.D.
Mr. Adam C. Vandervoort, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
69.77K
-7.68%
Ms. Kelly Bliss
Ms. Kelly Bliss
President, U.S. Group Health
President, U.S. Group Health
50.27K
-8.47%
Ms. Sandra L. Fenwick
Ms. Sandra L. Fenwick
Independent Director
Independent Director
40.43K
--
Mr. David L. Shedlarz
Mr. David L. Shedlarz
Independent Director
Independent Director
32.28K
+117.92%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de abr
Divisa: USDActualizado: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q3
FY2022Q2
Por negocioUSD
Nombre
Ganancia
Proporción
Access Fees Revenue
2.22B
86.21%
Other
354.35M
13.79%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
2.16B
84.06%
International
409.62M
15.94%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Access Fees Revenue
2.22B
86.21%
Other
354.35M
13.79%
Estadísticas de accionistas
Actualizado: vie., 16 de may
Actualizado: vie., 16 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
11.19%
BlackRock Institutional Trust Company, N.A.
7.28%
Renaissance Technologies LLC
3.73%
Point72 Asset Management, L.P.
3.71%
Two Sigma Investments, LP
3.02%
Other
71.06%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
11.19%
BlackRock Institutional Trust Company, N.A.
7.28%
Renaissance Technologies LLC
3.73%
Point72 Asset Management, L.P.
3.71%
Two Sigma Investments, LP
3.02%
Other
71.06%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
32.79%
Hedge Fund
17.95%
Investment Advisor
17.80%
Research Firm
4.68%
Individual Investor
1.09%
Bank and Trust
0.64%
Pension Fund
0.48%
Sovereign Wealth Fund
0.10%
Venture Capital
0.04%
Other
24.43%
Participación institucional
Actualizado: mar., 4 de mar
Actualizado: mar., 4 de mar
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
1023
133.05M
75.84%
-33.56M
2024Q4
1063
134.61M
77.51%
-37.55M
2024Q3
1133
134.94M
78.45%
-32.89M
2024Q2
1195
142.47M
83.22%
-14.73M
2024Q1
1317
130.90M
77.27%
-19.41M
2023Q4
1432
129.36M
77.56%
-18.52M
2023Q3
1538
125.63M
75.92%
-38.92M
2023Q2
1640
129.13M
78.35%
-41.97M
2023Q1
1761
137.47M
83.88%
-27.34M
2022Q4
1860
135.36M
83.16%
-23.04M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
18.43M
10.61%
+1.03M
+5.92%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
13.67M
7.87%
-227.05K
-1.63%
Dec 31, 2024
Renaissance Technologies LLC
5.67M
3.27%
+763.26K
+15.54%
Dec 31, 2024
Point72 Asset Management, L.P.
11.18M
6.44%
+2.81M
+33.63%
Dec 31, 2024
Two Sigma Investments, LP
4.28M
2.46%
+3.56M
+492.73%
Dec 31, 2024
Dimensional Fund Advisors, L.P.
3.53M
2.03%
+8.89K
+0.25%
Dec 31, 2024
State Street Global Advisors (US)
5.08M
2.92%
+446.18K
+9.63%
Dec 31, 2024
Geode Capital Management, L.L.C.
3.95M
2.27%
+22.66K
+0.58%
Dec 31, 2024
Maple Rock Capital Partners, Inc.
3.56M
2.05%
+2.33M
+189.51%
Dec 31, 2024
Wellington Management Company, LLP
3.14M
1.81%
-60.80K
-1.90%
Dec 31, 2024
Ver más
ETFs relacionados
Actualizado: vie., 6 de jun
Actualizado: vie., 6 de jun
Nombre
Proporción
Counterpoint Quantitative Equity ETF
1.88%
Global X HealthTech ETF
1.35%
Fidelity Digital Health ETF
1.12%
First Trust Indxx Metaverse ETF
0.98%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.59%
Principal U.S. Small-Cap ETF
0.45%
Langar Global HealthTech ETF
0.45%
SPDR S&P Kensho New Economies Composite ETF
0.24%
iShares U.S. Healthcare Providers ETF
0.21%
Avantis US Small Cap Equity ETF
0.14%
Ver más
Counterpoint Quantitative Equity ETF
Proporción1.88%
Global X HealthTech ETF
Proporción1.35%
Fidelity Digital Health ETF
Proporción1.12%
First Trust Indxx Metaverse ETF
Proporción0.98%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción0.59%
Principal U.S. Small-Cap ETF
Proporción0.45%
Langar Global HealthTech ETF
Proporción0.45%
SPDR S&P Kensho New Economies Composite ETF
Proporción0.24%
iShares U.S. Healthcare Providers ETF
Proporción0.21%
Avantis US Small Cap Equity ETF
Proporción0.14%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
